Lynne Fiore, NP
Women's Health · Scottsdale, AZNPI 1851448765
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 63 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $611 and has fallen 93.7% since, to $39 in 2025.
Across 63 payments — averaging $16.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$192
- Scynexis, Inc.$119
- Myovant Sciences Inc.$104
- Agile Therapeutics, Inc.$90
- Evofem Biosciences, Inc.$68
- Therapeuticsmd, Inc.$63
- plus $403 from 15 others
What the payments were for
- Food & beverage$1,02198%
- Gifts$182%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 16 | $192 |
| Scynexis, Inc. | 7 | $119 |
| Myovant Sciences Inc. | 5 | $104 |
| Agile Therapeutics, Inc. | 5 | $90 |
| Evofem Biosciences, Inc. | 4 | $68 |
| Therapeuticsmd, Inc. | 4 | $63 |
| Aspira Women's Health Inc | 2 | $58 |
| Mayne Pharma Commercial LLC | 2 | $40 |
| Astellas Pharma US Inc | 2 | $39 |
| Mylan Pharmaceuticals Inc. | 2 | $37 |
| Amgen | 2 | $36 |
| Pfizer | 2 | $35 |
| Exeltis, USA Inc. | 2 | $32 |
| Baxter Healthcare | 1 | $23 |
| BD | 1 | $20 |
| Ascend Therapeutics US, LLC | 1 | $18 |
| Lupin Inc. | 1 | $16 |
| Bayer | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Pacira Pharmaceuticals Incorporated | 1 | $12 |
| Coopersurgical, Inc. | 1 | $11 |
How this compares
$1,039 in reported general payments places this provider in the 70th percentile of 176 women's health providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 375 | $16,993 |
| MyrbetriqMirabegron | 12 | $8,348 |
| Estradiol (Twice Weekly)Estradiol | 35 | $3,686 |
| ProgesteroneProgesterone, Micronized | 65 | $2,186 |
| Clindamycin Phosphate | 29 | $1,710 |
| ValacyclovirValacyclovir Hcl | 31 | $1,539 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 36 | $989 |
| Clobetasol Propionate | 23 | $803 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 23 | $475 |
| Terconazole | 18 | $455 |
| Bupropion Hcl SrBupropion Hcl | 11 | $226 |
| Fluconazole | 36 | $151 |
| Alendronate Sodium | 24 | $113 |
| Fluoxetine Hcl | 16 | $45 |
| Misoprostol | 12 | $19 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $39 | $8,34812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 176 women's health providers in Arizona.
Other women's health in Scottsdale
- Trina LlewellynScottsdale$4K
- Paula MazzacanoScottsdale$2K
- Mary FrazeeScottsdale$2K
- Dale DorseyScottsdale$2K
- Darla McKameyScottsdale$1K
- Jill LambertScottsdale$1K
- Holly PelaScottsdale$1K
- Elia ValdiviaScottsdale$1K
- Carol BafaloukosSun City$13K
- Shannon McGrathTempe$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.